Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
PCR Biosystems
PCR Biosystems
Activities:
Ingredients
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
PCR Biosystems launches new family of qPCR reagent mixes
In research laboratories, qPCR assays are used for a diverse range of applications
Ingredients
PCR Biosystems launches lyophilisable reagent mix
Lyophilised test formats may help circumvent transport and storage challenges
Ingredients
Bst Polymerase reagents for accelerated DNA amplification
PCR Biosystems’ range has been validated for qualitative detection of the SARS-CoV-2 nucleic acid
Research & Development
PCR Biosystems introduces quantification kit for Illumina
NGSBIO Library Quant kit enables quantification across a range of sample types, concentrations, fragment sizes and GC content
Analysis
PCR Biosystems launches standalone RNase Inhibitor
While it has previously been a component of several PCR Biosystems kits, the RNase inhibitor is now available as a standalone product
Ingredients
PCR Biosystems scales up COVID-19 testing enzyme production
UK-based PCR Biosystems has introduced bulk pack sizes of this key product, to further support customers in high-throughput COVID-19 testing
Subscribe now